FGC
CYTK icon

Financial Gravity Companies’s Cytokinetics CYTK Stock Holding History

Financial Gravity Companies’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$1K Buy
+109
New +$800 ﹤0.01% 1059
2018
Q1 		$1K Sell
119
-9,183
-99% -$78.7K ﹤0.01% 1101
2017
Q4 		$86K Buy
+9,302
New +$106K 0.1% 204

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Financial Gravity Companies's CYTK Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Cytokinetics (CYTK) in Q4 2018: 109 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1059 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in CYTK as recently as Q1 2018.

Financial Gravity Companies first reported a position in CYTK in Q4 2017 and has held it in 3 quarters since. The position peaked at $86K in Q4 2017. 137 funds tracked by Wall St. Rank hold CYTK as of Q4 2018.

  • Financial Gravity Companies held 109 shares of Cytokinetics worth $1K as of Q4 2018.
  • Cytokinetics was a new Financial Gravity Companies position in Q4 2018.
  • Cytokinetics made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #1059 holding.
  • Financial Gravity Companies first reported a position in Cytokinetics in Q4 2017 and has held it in 3 quarters since.
  • Financial Gravity Companies's Cytokinetics position peaked at $86K in Q4 2017.
  • 137 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.